Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 Per Share
-
Shares outstanding
-
14,033,333
-
Total 13F shares
-
12,121,173
-
Share change
-
-321,661
-
Total reported value
-
$542,270,562
-
Put/Call ratio
-
75%
-
Price per share
-
$44.72
-
Number of holders
-
160
-
Value change
-
-$11,877,450
-
Number of buys
-
80
-
Number of sells
-
65
Institutional Holders of Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) as of Q1 2016
As of 31 Mar 2016 Anika Therapeutics, Inc. - Common Stock, Par Value $0.01 Per Share (ANIK) had 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,121,173 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, DIMENSIONAL FUND ADVISORS LP, THOMPSON SIEGEL & WALMSLEY LLC, VANGUARD GROUP INC, BTIM Corp., HealthInvest Partners AB, BlackRock Institutional Trust Company, N.A., AMI ASSET MANAGEMENT CORP, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 160 institutional shareholders of the security as of 31 Mar 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.